2 Former Wall Street Pros Share Their 5 Innovative Stocks To Buy
At the recent Global Financial Summit, two former Wall Street professionals shared their picks for innovative stocks to buy for the opportunity to profit from…
Shares
“An Opportunity For Massive Profits”: 3 Top Stocks Under $10 A Share
“We are seeing an opportunity for massive profits in stocks under $10 a share,” declares the author of today’s article, who explains that “As so…
Is This Biopharma Company With A Unique Business A Buy?
With a portfolio currently comprised of 45 commercial products and five developmental-stage candidates in various areas, including rare disease and neurology, the company featured in…
These Recent Insider Purchases Could Be Strong Signals To Potential Investors
When it comes to insider buying, the author of today’s article notes that “Conventional wisdom says that insiders and 10% owners really only buy shares…
4 Under-$10 Biotech Stocks With Solid Upside Potential For Aggressive Traders
“Many investors, especially more aggressive traders, look at lower-priced stocks as a way to not only make some good money but to get a higher…
This Biotech Stock Could Be A Good “Bad News Buy”
When it comes to the biotech stock that’s the focus of today’s article, which plummeted in mid-October when the company abruptly pulled the plug on…
This Biotech’s Mission Is To Go Global – And Revolutionize Cancer Treatment
“We have a $5 billion market cap now. The next stage is for us to get to $20 billion,” declares the chief executive of the…
This Company Is Essential To Biotechs – And Its Shares May Be Poised To Break Out
“The company I’m showing you today is essential to biotech stocks. It’s a ‘biotech-enabler,’” declares the author of today’s article in regards to a firm…
U.S. Traders May Be Accidentally Buying This Biotech Stock – But It May Be Worth Owning Anyways!
Shares of the biotech highlighted in today’s article have soared this year, but is this performance due to factors such as the COVID-19 drug the…
More Evidence That Biotech Is The “Next Gold Mine”
If you need any further evidence of just how much the COVID-19 pandemic has increased the allure of biotechnology stocks, consider the little-known Chinese biotech…